Mediq (PRIVATE.MEDIQ)

Overall impact
B (72)

Commentary

Mediq is a strong overall performer. With a 'B' rating of 71.6 for overall impact (85th percentile compared to all companies), Mediq ranks 4th out of 14 industry peers, behind Edwards Lifesciences, Philips and Smith & Nephew, and ahead of Boston Scientific, Becton Dickinson, Zimmer Biomet and 7 others. On top material causes for Mediq's industry (Healthcare Equipment), Mediq performs well in Accountable Institutions (89.6 score), Child and Maternal Health (94.9), Equal Pay and Opportunity (94.8) and 5 other causes where it received an 'A' score and performs poorly in Disease Eradication (36.1 score).
Impact
Cause PRIVATE.MEDIQ
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Founded
1899
Employees
1,824
Sector
Health Care
Industry
Health Care Providers & Services
Sub-industry
Health Care Distributors
SASB industry
Medical Equipment & Supplies
Headquarters
Netherlands
Share classes
PRIVATE.MEDIQ
Description
Supplier of pharmaceuticals and medical gear intended to serve clinics, patients, hospitals, and healthcare institutions. The company offers medical devices including stethoscopes, diagnostic equipment, gloves, and wound care products focused on the field of airway care, complex wounds, and stoma care. Additionally, the company provides medical and tube feeding solutions. This comprehensive approach helps patients with chronic health issues live an independent life. The emphasis on various medical devices ensures that healthcare professionals have the tools they need to support patient care effectively.
Material causes
Ethos considers the following causes material for Mediq, based on its industry sub-industry Health Care Distributors. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.